LONG BEACH, Calif. & WASHINGTON--(BUSINESS WIRE)--April 3, 2006--Results of a study presented today at the 97th Annual Meeting of the American Association of Cancer Research (AACR) affirms the utility of ex-vivo analysis of programmed cell death in human tumor microspheroids as a means to guide clinical trial development.
